Jan Kaufmann
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Emergency Medicine top 10%
- Cardiac Arrest and Resuscitation
- Hematological disorders and diagnostics
Papers in
-
- Atrial Fibrillation Management and Outcomes 4
- Antiplatelet Therapy and Cardiovascular Diseases 2
-
- Peroxisome Proliferator-Activated Receptors 2
- Co-authors
- Eckart Fleck (12 shared papers)John A. Thompson (1 shared paper)Eric M. Bonnem (1 shared paper)Pamela G. Kidd (1 shared paper)A Fefer (1 shared paper)Philipp Stawowy (8 shared papers)Heike Meýborg (5 shared papers)Kai Kappert (6 shared papers)
- Journals
- Journal of Interventional Cardiac Electrophysiology (3 papers)Biochemical and Biophysical Research Communications (2 papers)Coronary Artery Disease (2 papers)Resuscitation (2 papers)Circulation (1 paper)
- Partner nations
- GermanyChinaUnited States
In The Last Decade
Jan Kaufmann
17 papers receiving 385 citations
Peers
Comparison fields: 5 of 61
- Hematology 109
- Emergency Medicine 53
- Cardiology and Cardiovascular Medicine 89
- Oncology 79
- Immunology 58
Countries citing papers authored by Jan Kaufmann
This map shows the geographic impact of Jan Kaufmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Kaufmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Kaufmann more than expected).
Fields of papers citing papers by Jan Kaufmann
This network shows the impact of papers produced by Jan Kaufmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Kaufmann. The network helps show where Jan Kaufmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan Kaufmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 144 | |
| 2 | 2009 | 39 | |
| 3 | 2010 | 38 | |
| 4 | 2011 | 31 | |
| 5 | 2012 | 27 | |
| 6 | 2010 | 24 | |
| 7 | 2014 | 20 | |
| 8 | 2016 | 18 | |
| 9 | 2009 | 15 | |
| 10 | 2019 | 11 | |
| 11 | 2013 | 8 | |
| 12 | 2014 | 4 | |
| 13 | 2015 | 3 | |
| 14 | 2009 | 3 | |
| 15 | 2015 | 2 | |
| 16 | 2008 | 2 | |
| 17 | 2009 | 1 |
About Jan Kaufmann
Jan Kaufmann is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Oncology, Emergency Medicine and Cancer Research, having authored 17 papers that have together received 390 indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (4 papers), Peroxisome Proliferator-Activated Receptors (2 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Acute Myeloid Leukemia Research (1 paper), Venous Thromboembolism Diagnosis and Management (1 paper), Hematological disorders and diagnostics (1 paper), Nerve injury and regeneration (1 paper) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Hematology (109 citations), Emergency Medicine (53 citations), Cardiology and Cardiovascular Medicine (89 citations), Oncology (79 citations) and Immunology (58 citations). Jan Kaufmann has collaborated with scholars based in Germany, China and United States. Frequent co-authors include Eckart Fleck, John A. Thompson, Eric M. Bonnem, Pamela G. Kidd, A Fefer, Philipp Stawowy, Heike Meýborg, Kai Kappert, Charalampos Kriatselis and Daniel J. Urban. Their work appears in journals such as Journal of Interventional Cardiac Electrophysiology, Biochemical and Biophysical Research Communications, Coronary Artery Disease, Resuscitation and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.